DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
de Bruijne EL, Gils A, Rijken DC. et al.
High thrombin activatable fibrinolysis inhibitor levels are associated with an increased risk of premature peripheral arterial disease.
Thromb Res 2011;
127 (03) 254-258
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.